GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Beginning Cash Position

OncoTherapy Science (TSE:4564) Beginning Cash Position : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Beginning Cash Position?

OncoTherapy Science's Beginning Cash Position for the quarter that ended in Sep. 2024 was 円0.0 Mil.

OncoTherapy Science's annual Beginning Cash Position declined from Mar. 2022 (円2,899.1 Mil) to Mar. 2023 (円1,836.9 Mil) and declined from Mar. 2023 (円1,836.9 Mil) to Mar. 2024 (円1,117.6 Mil).


OncoTherapy Science Beginning Cash Position Historical Data

The historical data trend for OncoTherapy Science's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Beginning Cash Position Chart

OncoTherapy Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,857.67 4,713.95 2,899.09 1,836.91 1,117.64

OncoTherapy Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


OncoTherapy Science Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoTherapy Science Business Description

Traded in Other Exchanges
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines